GENEVA, Oct. 1 -- ONCOC4, INC. filed a patent application (US2026/018999) for “COMPOSITION AND METHOD FOR SYNTHESIZING PEGYLATED URICASE-DRUG CONJUGATES TO MITIGATE ANTI-DRUG ANTIBODY AND THEIR THERAPEUTIC USE”. With publication no. WO/2026/193334, here are the other details related to the patent application:

Kind: Initial Publication without ISR [A2]

IPC: A61K 47/60

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....